• Electro Power Systems

     |  Paris

    81636b9331ed-e438-486c-a552-f9880360e9b6

    Electro Power Systems

    EnterNext welcomes Electro Power Systems on Euronext in Paris

    Carlalberto Guglielminotti, CEO of Electro Power Systems, rings the opening bell.

    Electro Power Systems specializes in developing and manufacturing hydrogen-based systems for energy storage. The systems storage capacity (10 KWh up to 100 MWh) is an answer to the Energy Transition ranging from the auxiliary power supply (backup for telecom towers and data centers) to solutions for supporting the electricity grid for transmission and distribution (smart grids and renewables' integration) and finally to leverage a distrusted generation model with a full off-grid infrastructure.

    Paris
  • Electro Power Systems

     |  Paris

    81636b9331ed-e438-486c-a552-f9880360e9b6

    Electro Power Systems

    EnterNext welcomes Electro Power Systems on Euronext in Paris

    Carlalberto Guglielminotti, CEO of Electro Power Systems, rings the opening bell.

    Electro Power Systems specializes in developing and manufacturing hydrogen-based systems for energy storage. The systems storage capacity (10 KWh up to 100 MWh) is an answer to the Energy Transition ranging from the auxiliary power supply (backup for telecom towers and data centers) to solutions for supporting the electricity grid for transmission and distribution (smart grids and renewables' integration) and finally to leverage a distrusted generation model with a full off-grid infrastructure.

    Paris
  • Sensorion

     |  Paris

    816214e77663-6554-463b-8407-5754dcc6eb75

    Sensorion

    EnterNext welcomes Sensorion on Alternext in Paris

    Laurent Nguyen, CEO of Sensorion, rings the opening bell.

    Sensorion specializes in the research and development of medicines for the treatment of inner ear disorders (dizziness or loss of balance, hearing problems, tinnitus, etc.).

    The company has three products in its portfolio, all in the final phases of pre-clinical development.

    Paris
  • Sensorion

     |  Paris

    816214e77663-6554-463b-8407-5754dcc6eb75

    Sensorion

    EnterNext welcomes Sensorion on Alternext in Paris

    Laurent Nguyen, CEO of Sensorion, rings the opening bell.

    Sensorion specializes in the research and development of medicines for the treatment of inner ear disorders (dizziness or loss of balance, hearing problems, tinnitus, etc.).

    The company has three products in its portfolio, all in the final phases of pre-clinical development.

    Paris
  • Plant Advanced Technologies

     |  Paris

    81519cc485cf-53f4-4029-998c-356c8e9316fb

    Plant Advanced Technologies

    EnterNext welcomes Plant Advanced Technologies on Alternext in Paris

    Jean-Paul Fèvre, Founder and CEO of Plant Advanced Technologies (symbol: ALPAT), rings the opening bell.

    Plant Advanced Technologies specializes in producing plant molecules and extracts for the pharmaceutical and cosmetic sectors. The company offers research contracts to industrial firms for updating technologies on new plants and supply contracts for molecules obtained from these plants.

     

    Paris
  • Plant Advanced Technologies

     |  Paris

    81519cc485cf-53f4-4029-998c-356c8e9316fb

    Plant Advanced Technologies

    EnterNext welcomes Plant Advanced Technologies on Alternext in Paris

    Jean-Paul Fèvre, Founder and CEO of Plant Advanced Technologies (symbol: ALPAT), rings the opening bell.

    Plant Advanced Technologies specializes in producing plant molecules and extracts for the pharmaceutical and cosmetic sectors. The company offers research contracts to industrial firms for updating technologies on new plants and supply contracts for molecules obtained from these plants.

     

    Paris
  • EnterNext welcomes OSE Pharma on Euronext in Paris

     |  Paris

    81455c94b09a-ab28-4cdf-b059-d13a7cc71681

    EnterNext welcomes OSE Pharma on Euronext in Paris

    Dominique Costantini, co-founder et CEO of OSE Pharma, rings the closing bell.

    OSE Pharma is a biotechnology group that specializes in the research and development of therapeutic products for the treatment of cancers and lung disease.
    At the end of 2013, the group had a portfolio of 5 products in development phase, including 4 in phase II (colon, breast and ovarian cancer, and cystic fibrosis) and 1 in phase III (lung cancer).

    Paris
  • EnterNext welcomes OSE Pharma on Euronext in Paris

     |  Paris

    81455c94b09a-ab28-4cdf-b059-d13a7cc71681

    EnterNext welcomes OSE Pharma on Euronext in Paris

    Dominique Costantini, co-founder et CEO of OSE Pharma, rings the closing bell.

    OSE Pharma is a biotechnology group that specializes in the research and development of therapeutic products for the treatment of cancers and lung disease.
    At the end of 2013, the group had a portfolio of 5 products in development phase, including 4 in phase II (colon, breast and ovarian cancer, and cystic fibrosis) and 1 in phase III (lung cancer).

    Paris
  • 814406960ab3-2b68-435a-a498-085a3f581d96

    EnterNext welcomes Cerenis Therapeutics on Euronext in Paris

    Jean-Louis Dasseux, President and CEO of Cerenis Therapeutics, rings the opening bell.

    Cerenis Therapeutics is specialized in research & development into HDL therapies (High Density lipoproteins) intended for the treatment of cardiovascular and metabolic disorders. HDLs, also known as good cholesterol, are fat and protein complexes that contribute to the transportation of cholesterol from the body's tissues to the liver and are linked to a decrease in the risk of atherosclerosis and coronary diseases.
    At the end of 2014, the firm boasted a portfolio of 6 products, with 3 in pre-clinical development and 3 in phase I of clinical development.

    Paris
  • 814406960ab3-2b68-435a-a498-085a3f581d96

    EnterNext welcomes Cerenis Therapeutics on Euronext in Paris

    Jean-Louis Dasseux, President and CEO of Cerenis Therapeutics, rings the opening bell.

    Cerenis Therapeutics is specialized in research & development into HDL therapies (High Density lipoproteins) intended for the treatment of cardiovascular and metabolic disorders. HDLs, also known as good cholesterol, are fat and protein complexes that contribute to the transportation of cholesterol from the body's tissues to the liver and are linked to a decrease in the risk of atherosclerosis and coronary diseases.
    At the end of 2014, the firm boasted a portfolio of 6 products, with 3 in pre-clinical development and 3 in phase I of clinical development.

    Paris
  • 81366414e463-0bfb-49af-8dd9-47d66286907c

    PSA Peugeot Citroën celebrates return to CAC 40 at Paris opening bell

    PSA Peugeot Citroën is back in the Index, driven by first results of its rebuilding plan "Back in the Race".

    The very first year of its plan, PSA Peugeot Citroën achieved ahead on its target 2 main objectives out of 3, by generating €2.2 billion in operating Free Cash Flow and becoming net debt free at the en of 2014.
    To celebrate this come back, Jean-Baptiste de Chatillon, CFO of PSA Peugeot Citroën rang the bell marking the opening of trading on markets in Paris.

    Paris
  • 81366414e463-0bfb-49af-8dd9-47d66286907c

    PSA Peugeot Citroën celebrates return to CAC 40 at Paris opening bell

    PSA Peugeot Citroën is back in the Index, driven by first results of its rebuilding plan "Back in the Race".

    The very first year of its plan, PSA Peugeot Citroën achieved ahead on its target 2 main objectives out of 3, by generating €2.2 billion in operating Free Cash Flow and becoming net debt free at the en of 2014.
    To celebrate this come back, Jean-Baptiste de Chatillon, CFO of PSA Peugeot Citroën rang the bell marking the opening of trading on markets in Paris.

    Paris
  • 8130f5de9045-b875-4d80-a186-da85018c4d90

    CADES rings the bell to celebrate their bond issuance in RMB

    Patrice Ract Madoux, Chairman of CADES, closes the trading day in Paris to celebrate the listing of their bond issuance in RMB

    Created in 1996, CADES (Caisse d'Amortissement de la Dette Sociale)  is an administrative public body owned and controlled by the French State. Its mission is to amortise the French social debt. To successfuly achieve its mission entrusted by French Parliament, CADES has the possibility to issue tradable debt securities. The outstanding success of this transaction underlines the confidence that international investors have in CADES, one of the first European issuer. They particularly appreciate the solidity of the French social debt amortization mechanism, as well as the quality of the resource that is collected among the population under the supervision of the French Parliament and the Constitutional Council. Since its establishment, CADES has amortised a total of €84.1 billion of French social debt on a total of €216.7 billion assumed since inception. This reduction in the French public debt is equivalent in amount to 4 percentage points of 2013 GDP. When the interest saving on the amortised debt is taken into account, the reduction equates to more than 5 per cent of GDP.

    Paris
  • 8130f5de9045-b875-4d80-a186-da85018c4d90

    CADES rings the bell to celebrate their bond issuance in RMB

    Patrice Ract Madoux, Chairman of CADES, closes the trading day in Paris to celebrate the listing of their bond issuance in RMB

    Created in 1996, CADES (Caisse d'Amortissement de la Dette Sociale)  is an administrative public body owned and controlled by the French State. Its mission is to amortise the French social debt. To successfuly achieve its mission entrusted by French Parliament, CADES has the possibility to issue tradable debt securities. The outstanding success of this transaction underlines the confidence that international investors have in CADES, one of the first European issuer. They particularly appreciate the solidity of the French social debt amortization mechanism, as well as the quality of the resource that is collected among the population under the supervision of the French Parliament and the Constitutional Council. Since its establishment, CADES has amortised a total of €84.1 billion of French social debt on a total of €216.7 billion assumed since inception. This reduction in the French public debt is equivalent in amount to 4 percentage points of 2013 GDP. When the interest saving on the amortised debt is taken into account, the reduction equates to more than 5 per cent of GDP.

    Paris
  • 811579875823-4168-4ccc-b143-d3c89d17c68e

    Euronext celebrates International Women’s Day 2015 in Paris

    Female personalities from BNP Paribas, Groupe BCPE, Ossiam, Korn Ferry ring the opening bell.

    For the International Women's Day 2015, Dominique Aubernon, Director of BNP Paribas New Zealand LTD, Marguerite Bérard-Andrieu, Deputy Exceutive Director of Groupe BPCE, Isabelle Bourcier, Head of Business Development of Ossiam, Inès de Dinechin, Board Member of Euronext London Limited, and Victoria Lorenz, Senior Client Partner of Korn Ferry, wish to contribute to improve and accelerate women's access to higher level in organizational scale within societies.
    The bell ceremony has been followed by a roundtable on the theme of "Make it happen : Women & Careers in Finance" with these female personalities.

    Paris
  • 811579875823-4168-4ccc-b143-d3c89d17c68e

    Euronext celebrates International Women’s Day 2015 in Paris

    Female personalities from BNP Paribas, Groupe BCPE, Ossiam, Korn Ferry ring the opening bell.

    For the International Women's Day 2015, Dominique Aubernon, Director of BNP Paribas New Zealand LTD, Marguerite Bérard-Andrieu, Deputy Exceutive Director of Groupe BPCE, Isabelle Bourcier, Head of Business Development of Ossiam, Inès de Dinechin, Board Member of Euronext London Limited, and Victoria Lorenz, Senior Client Partner of Korn Ferry, wish to contribute to improve and accelerate women's access to higher level in organizational scale within societies.
    The bell ceremony has been followed by a roundtable on the theme of "Make it happen : Women & Careers in Finance" with these female personalities.

    Paris
  • EnterNext welcomes ECOSLOPS on Alternext in Paris

     |  Paris

    810326abd6ba-b7c2-48f2-afbd-9ab65549b0b3

    EnterNext welcomes ECOSLOPS on Alternext in Paris

    Michel Pingeot, CEO et co-founder of Ecoslops, rings the opening bell.

    ECOSLOPS gives a second life to oil residues from shipping and produces recycled marine fuels. The company operates an innovating technology in the treatment of marine hydrocarbon waste. Based on a strong and growing demand, ECOSLOPS provides an economically sustainable and ecologically relevant solution to all players of the marine waste industry. Its first industrial unit has already been launched. The production is progressively ramping-up. This success enables the company to commit to signing three new projects by 2017. ECOSLOPS has all the necessary advantages to become a major player in the treatment of marine hydrocarbon waste.

    Paris
  • EnterNext welcomes ECOSLOPS on Alternext in Paris

     |  Paris

    810326abd6ba-b7c2-48f2-afbd-9ab65549b0b3

    EnterNext welcomes ECOSLOPS on Alternext in Paris

    Michel Pingeot, CEO et co-founder of Ecoslops, rings the opening bell.

    ECOSLOPS gives a second life to oil residues from shipping and produces recycled marine fuels. The company operates an innovating technology in the treatment of marine hydrocarbon waste. Based on a strong and growing demand, ECOSLOPS provides an economically sustainable and ecologically relevant solution to all players of the marine waste industry. Its first industrial unit has already been launched. The production is progressively ramping-up. This success enables the company to commit to signing three new projects by 2017. ECOSLOPS has all the necessary advantages to become a major player in the treatment of marine hydrocarbon waste.

    Paris